Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01925781 · ClinicalTrials.gov registry record · Phase 4

e-Cigarettes Versus NRT Gum for Smoking Cessation

A Phase 4 study, sponsored by Creighton University.

Terminated
Registry status
Phase 4
Development phase
10
Enrollment target

NCT01925781 is a Phase 4 study that was terminated before completion, run by Creighton University. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01925781, a Phase 4 study, was terminated before completion, sponsored by Creighton University.

TERMINATED
Registry status
Phase 4
Development phase
10 participants
Enrollment target

Study Summary

This is a randomized trial comparing electronic cigarettes (e-Cigarettes) to nicotine gum for smoking cessation. Participants will be randomly assigned to either e-cigarette use or nicotine gum use during a quit attempt. All participants will have a one hour meeting with a tobacco treatment specialist to develop a quit plan and set a quit date. Quit status will be determined at 12 weeks after the quit date. Continued use of nicotine replacement (either e-Cigarette or nicotine gum) and satisfaction with the treatment assignment will be evaluated.

Interventions

  • DRUG Nicotine polacrilex
  • OTHER STAM 1100mAh CE4 eGo Clearomizer

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2013-08
Est. Completion 2013-11
Phase Phase 4

Sponsor

Creighton University

98 total trials

What the Registry Record Tells You About NCT01925781

The ClinicalTrials.gov registry entry for NCT01925781 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Nicotine polacrilex is the first listed.

NCT01925781 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01925781 about?

NCT01925781 is a clinical study titled "e-Cigarettes Versus NRT Gum for Smoking Cessation". This is a randomized trial comparing electronic cigarettes (e-Cigarettes) to nicotine gum for smoking cessation. Participants will be randomly assigned to either e-cigarette use or nicotine gum use during a quit attempt. All participants will have a one hour meeting with a tobacco treatment speciali...

What is the current status of trial NCT01925781?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2013-08. Estimated completion is 2013-11.

What interventions are being tested in trial NCT01925781?

The interventions under investigation include: Nicotine polacrilex (DRUG), STAM 1100mAh CE4 eGo Clearomizer (OTHER).

Who is sponsoring clinical trial NCT01925781?

This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.